Inverness Medical Press Release


 

TIDMCOT 
 
RNS Number : 9548W 
Inverness Medical Innovations, Inc 
05 August 2009 
 
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR 
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE 
RELEVANT LAWS OF SUCH JURISDICTION 
 
 
FOR IMMEDIATE RELEASE 
5th AUGUST 2009 
 
 
INVERNESS MEDICAL INNOVATIONS ANNOUNCES 
OFFERING OF $150 MILLION OF SENIOR NOTES 
WALTHAM, Mass. Inverness Medical Innovations, Inc. (NYSE: IMA - News), a global 
leader in enabling individuals to take charge of their health at home through 
the merger of rapid diagnostics and health management, today announced that it 
intends to offer $150 million of senior notes due 2016 in a public offering. 
Further information can be found at - 
http://www.sec.gov/Archives/edgar/data/1145460/000095012309029635/b76664aiexv99 
1.htm 
About Inverness Medical Innovations, Inc. 
By developing new capabilities in near-patient diagnosis, monitoring and health 
management, Inverness Medical Innovations enables individuals to take charge of 
improving their health and quality of life at home. Inverness' global leading 
products and services, as well as its new product development efforts, focus on 
infectious disease, cardiology, oncology, drugs of abuse and women's health. 
Inverness is headquartered in Waltham, Massachusetts. 
For additional information on Inverness Medical Innovations, please visit 
www.invmed.com. 
Enquiries: 
Inverness Medical Innovations 
Doug Guarino001 781 647 3900 
Jon Russell    001 781 647 3900 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 OUPUUUQWRUPBGAA

Concateno (LSE:COT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024